Your browser doesn't support javascript.
loading
Proliferative exhausted CD8+ T cells exacerbate long-lasting anti-tumor effects in human papillomavirus-positive head and neck squamous cell carcinoma.
Cheng, Danni; Qiu, Ke; Rao, Yufang; Mao, Minzi; Li, Li; Wang, Yan; Song, Yao; Chen, Junren; Yi, Xiaowei; Shao, Xiuli; Huang, Shao Hui; Zhang, Yi; Chen, Xuemei; Wu, Sisi; Yu, Shuaishuai; Liu, Jun; Wang, Haiyang; Peng, Xingchen; Li, Daibo; Yang, Lin; Chen, Li; Ying, Zhiye; Zheng, Yongbo; Zheng, Meijun; Ying, Binwu; Zeng, Xiaoxi; Zhang, Wei; Xu, Wei; Liu, Geoffrey; Chen, Fei; Yu, Haopeng; Zhao, Yu; Ren, Jianjun.
Affiliation
  • Cheng D; Department of Oto-Rhino-Laryngology, and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Qiu K; Department of Oto-Rhino-Laryngology, and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Rao Y; Department of Oto-Rhino-Laryngology, and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Mao M; Department of Oto-Rhino-Laryngology, and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Li L; Institute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu, China.
  • Wang Y; Research Core Facility of West China Hospital, Sichuan University, Chengdu, China.
  • Song Y; Department of Oto-Rhino-Laryngology, and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Chen J; West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China.
  • Yi X; Department of Oto-Rhino-Laryngology, and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Shao X; Department of Oto-Rhino-Laryngology, and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Huang SH; Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.
  • Zhang Y; Research Core Facility of West China Hospital, Sichuan University, Chengdu, China.
  • Chen X; Research Core Facility of West China Hospital, Sichuan University, Chengdu, China.
  • Wu S; Research Core Facility of West China Hospital, Sichuan University, Chengdu, China.
  • Yu S; Research Core Facility of West China Hospital, Sichuan University, Chengdu, China.
  • Liu J; Department of Oto-Rhino-Laryngology, and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Wang H; Department of Oto-Rhino-Laryngology, and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Peng X; Department of Biotherapy and National Clinical Research Center for Geriatrics, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Li D; Department of Oto-Rhino-Laryngology, and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Yang L; MinSheng Ear-Nose-Throat Hospital, Chengdu, China.
  • Chen L; MinSheng Ear-Nose-Throat Hospital, Chengdu, China.
  • Ying Z; West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China.
  • Zheng Y; Department of Oto-Rhino-Laryngology, and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Zheng M; Department of Oto-Rhino-Laryngology, and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Ying B; Department of Oto-Rhino-Laryngology, and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Zeng X; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
  • Zhang W; Department of Oto-Rhino-Laryngology, and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Xu W; West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China.
  • Liu G; Institute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu, China.
  • Chen F; Department of Biostatistics, Princess Margaret Cancer Centre and Dalla Lana School of Public Health, Toronto, Canada.
  • Yu H; Department of Medicine, Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Canada.
  • Zhao Y; Department of Oto-Rhino-Laryngology, and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Ren J; Department of Oto-Rhino-Laryngology, and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
Elife ; 122023 02 22.
Article in En | MEDLINE | ID: mdl-36811599
The survival prognosis of human papillomavirus (HPV)-positive and HPV-negative head and neck squamous cell carcinoma (HNSCC) is largely different, and little is known about the anti-tumor mechanism of tumor-infiltrated exhausted CD8+ T cells (Tex) in HNSCC. We performed cell-level multi-omics sequencing on human HNSCC samples to decipher the multi-dimensional characteristics of Tex cells. A proliferative exhausted CD8+ T cell cluster (P-Tex) which was beneficial to survival outcomes of patients with HPV-positive HNSCC was identified. Interestingly, P-Tex cells expressed CDK4 genes as high as cancer cells, which could be simultaneously inhibited by CDK4 inhibitors and might be a potential reason for the ineffectiveness of CDK4 inhibitors in treating HPV-positive HNSCC. P-Tex cells could aggregate in the antigen-presenting cell niches and activate certain signaling pathways. Together, our findings suggest a promising role for P-Tex cells in the prognosis of patients with HPV-positive HNSCC by providing modest but persistent anti-tumor effects.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Papillomavirus Infections / Head and Neck Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Elife Year: 2023 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Papillomavirus Infections / Head and Neck Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Elife Year: 2023 Type: Article Affiliation country: China